Ajax-Loading

Novartis AG - Return On Assets

Novartis AG's Fiscal Year is From January To December - All Figures are in Percent.

The item "Return-On-Assets" stands at 13.91 percent as of 09/30/2025.

As of the end of Novartis AG's third quarter, the item "Return On Assets" stands at 13.91 Percent. This represents an increase of 0.59 percentage points compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -3.90 percentage points compared to the value the year prior.
The 1 year change in percentage points is -3.90.
The 3 year change in percentage points is -3.58.

The Serie's long term average value is 12.96 percent. It's latest available value, on 09/30/2025, is 0.95 percentage points higher, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is +8.16.
The Serie's change in percentage points from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -5.35.

Return On Assets for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Return On Assets905,699,262,464.00
LogoJohnson & Johnson - Return On Assets486,508,953,600.00
LogoAbbVie Inc - Return On Assets399,570,305,024.00
LogoRoche Holding AG - Return On Assets317,433,206,677.55
LogoAstraZeneca PLC - Return On Assets280,205,508,085.11